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Abstract Curcumin is a natural compound showing antiproli-
ferative properties. Recent studies suggest that these properties
might be due to its ability to induce apoptosis in tumor cells. As
mitochondria play a pivotal role in the induction of the apoptotic
process, we analyzed the effect of curcumin on mitochondrial
function. Curcumin induced an increase in rat liver mitochondrial
membrane permeability, resulting in swelling, loss of membrane
potential and inhibition of ATP synthesis. These effects were
mediated by the opening of the permeability transition pore.
Curcumin pore induction involved the oxidation of membrane
thiol functions and required the presence of low Ca2+ concentra-
tions. These data suggest that mitochondria might be a target by
which curcumin induces apoptosis of tumor cells. ß 2001 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Curcumin (CUR; 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-
heptadiene-3,5-dione) is a natural yellow pigment isolated
from the rhizome of Curcuma longa L. (turmeric). It possesses
a wide range of pharmacological properties including antiin-
£ammatory, hypocholesterolemic and antiinfectious activities
[1^3].
CUR has also been shown to display anticarcinogenesis
properties in a wide variety of cell lines [4,5] and in animals
[6,7]. Recently, it was suggested that the e¡ect of CUR could
be mediated through its ability to induce apoptosis of tumor
cells [8,9]. Similar results were found in osteoclasts [10] and in
thymocytes, but the features of the apoptotic cell death in-
duced by CUR appeared di¡erent from those observed with
the typical proapoptotic agent dexamethasone [11]. Growing
evidence suggests that mitochondria are involved in the in-
duction of the cell death program [12]. Numerous stimuli
can trigger an increase in mitochondrial membrane permeabil-
ity [13] which is due to the formation of a pore, called the
permeability transition pore (PTP), at the level of the contact
sites between the inner and the outer mitochondrial mem-
branes. PTP opening induces the collapse of the mitochon-
drial membrane potential (vi), respiration impairment and
the inhibition of ATP synthesis. It releases apoptogenic fac-
tors and can lead to cell death [14]. Therefore, novel antitu-
mor strategies now focus on mitochondria. A recent study
suggested that the apoptotic process mediated by CUR in
AK-5 tumor cells involved a hyperproduction of radical oxy-
gen species (ROS) and a loss of vi [15]. In the present study,
we examined the e¡ect of CUR on isolated liver mitochondria
and found that CUR is able to induce PTP opening.
2. Materials and methods
Rat liver mitochondria were isolated from male Wistar rats as de-
scribed previously [16]. Mitochondrial swelling was assessed by mea-
suring the change in absorbance of their suspension at 520 nm by
using a Hitachi0 model U-3000 spectrophotometer either in energized
or deenergized conditions as described by Elimadi et al. [16]. vi was
monitored by means of the £uorescent dye rhodamine 123 at the
excitation and emission wavelengths of 503 and 527 nm, respectively
[16]. Ca2 £ux and mitochondrial respiration were simultaneously
measured in a thermostat-controlled reaction chamber (4 ml) at
25‡C. Mitochondrial respiration was measured by means of a
Clark-type oxygen microelectrode ¢tted to an oxygen monitoring sys-
tem (Hansatech0). The concentration of Ca2 in the extramitochon-
drial medium was monitored using a speci¢c Ca2 electrode (Orion0)
connected to the auxiliary output of the oxygen monitoring system via
a 720 A Orion ionometer.
Lipid peroxidation was assayed as the generation of thiobarbituric
acid-reactive substances (TBARS) according to [17] and the genera-
tion of O32 was achieved as previously reported [17]. For this partic-
ular experiment, mitochondria were puri¢ed on a sucrose gradient [18]
to avoid microsome contamination. Cyclosporin A (CsA) was added
to the medium to inhibit mitochondrial swelling, which slightly inter-
fered with the spectroscopic detection of the reduction reaction.
Protein thiol content was measured according to [19] with some
modi¢cations. Brie£y, mitochondria (1 mg/ml) were incubated in the
respiration bu¡er in the presence of CUR or other agents in a total
volume of 1 ml for 15 min at 25‡C. After this time, 100 Wl of mito-
chondrial solution were added to 700 Wl of methanol and 200 Wl of
Tris^EDTA (250/20 mM; pH = 8.2 at 20‡C). 20 Wl of Ellman’s reagent
(10 mM) were then added and the reaction was incubated for 15 min
at room temperature. Absorbance of the medium was read at 410 nm
against an Ellman’s reagent blank. In order to estimate protein thiol
concentration, a glutathione concentration range was performed
under the same conditions.
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Curcumin (purity s 99%) was synthesized by Synthe-Pharma
(Seysses, France).
3. Results and discussion
3.1. Curcumin induces mitochondrial swelling
In the experiment depicted in Fig. 1A, rat liver mitochon-
dria energized with succinate were incubated for 1 min in a
sucrose phosphate bu¡er before the addition of increasing
concentrations of CUR. The light scattering of the mitochon-
drial suspension was then monitored. CUR induced mito-
chondrial swelling as attested by the decrease in absorbance
in a concentration-dependent manner; the maximal e¡ect was
obtained at 20 WM. This e¡ect was completely inhibited in the
presence of 1 WM CsA or 150 WM 2,6-di-tert-butyl-4-methyl-
phenol (BHT; Fig. 1B). Thus, CUR-induced mitochondrial
swelling is due to the opening of the CsA-dependent pore
[13,20]. This is con¢rmed by the fact that ubiquinone 0, which
has recently been shown to inhibit PTP opening [21], also
reversed CUR-induced swelling (Fig. 1B).
PTP opening was also assessed by measuring vi and Ca2
£ux. As shown in Fig. 2, 20 WM CUR collapsed vi and
induced Ca2 release. These e¡ects were prevented by 1 WM
CsA. These results are in agreement with the data of Jaruga et
al. [11], who observed a rapid collapse of vi after addition of
CUR to thymocytes. Under the same experimental conditions,
10 WM of the protonophore carbonyl cyanide m-chlorophen-
ylhydrazone (CCCP), which collapses vi and releases Ca2
(Fig. 2), was unable to induce swelling (Fig. 1B).
3.2. E¡ect of curcumin on mitochondrial respiration
Fig. 3A shows a polarographic determination of oxygen
consumption in mitochondria energized either with the com-
plex I substrate succinate or the complex II substrates pyru-
vate plus malate. CUR was introduced 90 s after O2 consump-
tion had reached its steady rate level. CUR increased the basal
O2 consumption when succinate was used as a substrate but
only a very small or no e¡ect was observed in the presence of
pyruvate plus malate. It should be noted that only a moderate
Fig. 1. Induction of mitochondrial swelling by curcumin (CUR).
Liver mitochondria were preincubated for 3 min in a bu¡er contain-
ing 0.25 M sucrose, 5 mM KH2PO4, and 6 mM succinate, pH = 7.2
at 25‡C. A: Induction of swelling by increasing concentrations of
curcumin, 2.5 WM (line b), 10 WM (line c), 15 WM (line d), 20 WM
(line e). Line a: No addition of CUR. Lines f and g: Mitochondria
were preincubated with 1 WM CsA (f) or 150 WM BHT (g) before
swelling induction. B: Swelling was induced by 20 WM CUR (line
a), in the presence of 2 WM rotenone (line b) and pyruvate/malate
(6/6 mM) instead of succinate (line c). Preincubation (3 min) of mi-
tochondria with either 10 WM CCCP (line d), 20 WM EGTA (line
e), 1 WM ruthenium red (line f), 20 WM NEM (line g) or 50 WM
ubiquinone 0 (line h) counteracted the e¡ect of CUR.
Fig. 2. E¡ect of curcumin (CUR) on mitochondrial membrane po-
tential (vi) and Ca2 £uxes. Mitochondria were suspended in the
incubation bu¡er described in Fig. 1 supplemented with 0.3 WM of
rhodamine 123 (A only). vi and Ca2 £uxes (A and B) were mea-
sured after the addition of 6 mM succinate, followed (arrow) by ei-
ther 20 WM CUR (line b), 10 WM CCCP (line c) or 20 WM CUR+
1 WM CsA (line d). Line a: No addition of CUR.
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swelling could be detected in the presence of pyruvate plus
malate (Fig. 1A).
These data underlined the predominant role of complex II
in the CUR-induced PTP opening. However, the CUR e¡ect
also depended on complex I activity. Addition of the complex
I inhibitor rotenone delayed mitochondrial swelling (Fig. 1A),
which was probably due to the presence of NADH in the
mitochondrial matrix. Indeed, under these conditions the ox-
idation of the pyridine nucleotides was inhibited, they remain
fully reduced and can contribute to the prevention of PTP
opening.
This indicates that complex I activity is not necessary for,
but can modulate, the e¡ect of CUR. This is in agreement
with recent observations which demonstrated a regulation of
the PTP by complex I in skeletal muscle mitochondria [22].
When we studied the e¡ect of this molecule on oxidative
phosphorylation, we observed that the respiratory control ra-
tio (RCR) and P/O values were decreased (Fig. 3B). This
e¡ect was not due to a direct action of the drug on ATP
synthase since the rate of state 3 (ADP-stimulated) respiration
remained constant (Fig. 3A) but is, as stated before, related to
an increase of the basal O2 consumption. These data rein-
forced the hypothesis that CUR induced PTP opening.
Interestingly, the respiratory chain inhibitors antimycin A,
myxothiazol and KCN and the uncoupler CCCP, prevented
the swelling induced by CUR. This indicates that the CUR
e¡ect may be independent of respiratory chain function since
the ¢rst agents block the electron transfer chain and thus O2
consumption, whereas uncouplers accelerate O2 consumption
[23,24]. This was con¢rmed by the experiments depicted in
Fig. 4A showing that CUR was able to induce swelling under
deenergizing conditions. The common property of these com-
pounds is to collapse vi which immediately either prevents
Ca2 entry or produces a leak of Ca2 outside mitochondrial
matrix. As PTP opening is highly dependent on intramito-
Fig. 3. Alteration of mitochondrial functional parameters in the
presence of increasing concentrations of curcumin. Mitochondrial
respiration (1 mg of protein/ml) was induced by the addition of suc-
cinate (6 mM) or pyruvate/malate (6/6 mM; A only, trace O) and
oxidative phosphorylation was initiated by the addition of 0.2 mM
ADP. O2 consumption recordings allowed the calculation of the
basal respiration rate (state 2, E), the rate of state 3 (ADP-stimu-
lated) respiration (a), the rate of state 4 (non-ADP-stimulated) res-
piration (F), of the respiratory control ratio (RCR = state 3/state 4),
and the P/O ratio (ADP used divided by O2 consumed in state 3
respiration).
Fig. 4. Dual e¡ect of curcumin (CUR) on mitochondrial swelling in
deenergized conditions. Mitochondria were preincubated for 3 min
in a bu¡er containing 0.15 M sucrose, 5 mM Tris^HCl, 2 WM rote-
none, 1 WM antimycin A, pH = 7.2 at 25‡C. A: Swelling was in-
duced by 20 WM CUR (arrow) in the absence (line a) or in the pres-
ence of 20 WM mersalyl (line b), 1 mM dithiothreitol (line c) or 20
WM NEM (line d). B: Swelling was induced by 10 WM t-BH in the
presence of 100 WM Ca2 (line a). It was inhibited by increasing
concentrations of CUR, 12.5 (line b), 17.5 (line c), 25 (line d) and
50 WM (line e).
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chondrial Ca2 concentration [25], we investigated whether
the CUR e¡ect was Ca2-dependent.
3.3. Ca2+ plays a crucial role in curcumin e¡ect
When 20 WM EGTA was added to the incubation medium,
swelling was completely prevented (Fig. 1B) and vi was
maintained (Fig. 2A). The same result was obtained when
mitochondria were not energized (no Ca2 entry) or when
they were preincubated with 1 WM ruthenium red, a well-
known inhibitor of the Ca2 uniporter [26], before CUR ad-
dition. This shows that the CUR e¡ect required the presence
of intramitochondrial Ca2. It should be noted that only a
low Ca2 concentration is required since Ca2 concentration
did not exceed 2 WM in our incubation medium.
3.4. Curcumin induces membrane protein thiol group oxidation
Multiple regulatory steps are involved in the modulation of
PTP activity. The pore can be opened by a wide variety of
agents, especially prooxidant compounds. Lehninger et al. [27]
were the ¢rst to point out the crucial role of redox phenom-
enon in the occurrence of PTP. More precisely, oxidation and
cross-linkage of membrane protein thiol groups appear to be
responsible for membrane permeabilization which was ob-
served with ROS generated by the respiratory chain in the
presence of oxidizing or of cross-linker agents [13]. Lipid per-
oxidation was also hypothesized to participate in the mecha-
nisms leading to pore opening [28]. Thus, we reinvestigated
the redox properties of CUR to analyze its e¡ect on PTP.
CUR has a complex redox pro¢le. It is an antioxidant agent
and a scavenger of free radicals [29] but it has also been
suggested that CUR-induced cell death could be mediated
by the generation of ROS [8].
Fig. 5A con¢rmed that CUR inhibited the production of
TBARS by liver membranes in a concentration-dependent
manner with an IC50 value of 0.35 WM. It is interesting to
note that for a 20 WM concentration (maximal swelling e¡ect,
Fig. 1A), a maximal lipid peroxidation inhibiting e¡ect was
observed.
In order to directly assess the potential role of ROS in the
induction of pore opening by CUR, we measured their pro-
duction during mitochondrial swelling. ROS are mainly pro-
duced at the level of complexes I and III of the respiratory
chain [30]. In normal conditions only about 2^4% of the oxy-
gen consumed is released in the mitochondrial matrix as a
superoxide radical (O32 ) which, following dismutation, can
generate H2O2. In this situation, H2O2 may react with mito-
chondrial Fe2, resulting in the formation of the hydroxyl
radical (HO) [31]. We therefore decided to study the e¡ect
of CUR on the production of both O32 and H2O2. Liver
mitochondria energized with succinate produced O32 . Anti-
mycin A, a complex III inhibitor, stimulated the phenomenon
while CUR inhibited O32 formation in a concentration-de-
pendent manner (Fig. 5B). It should be noted that CUR did
not show any e¡ect on the enzymatic activity of this complex
(data not shown) and thus the e¡ect of CUR cannot be re-
lated to a direct interaction with the complex III or with the
ubiquinone cycle as observed with resveratrol [17]. As we
veri¢ed that CUR did not reduce nitroblue tetrazolium (the
marker used to measure O32 production, Fig. 5B) in forma-
Fig. 5. Inhibition of lipid peroxidation and O32 production by cur-
cumin. A: Lipid peroxidation was assessed on liver membranes ob-
tained by di¡erential centrifugation. Liver was homogenized on ice
in a Tris bu¡er (50 mM) using a Te£on Potter homogenizer. The
homogenate was centrifuged at 1000Ug for 10 min and the super-
natant was centrifuged for 10 min at 15 000Ug. The resulting pellet
was discarded and the supernatant was centrifuged at 100 000Ug
for 20 min. The ¢nal pellet was suspended in NaCl 0.9%. Mem-
branes (0.2 mg/ml proteins) were incubated in a total volume of
1 ml in the presence of a mixture of Fe2/Fe3 (50 WM/150 WM) for
30 min. The reaction was stopped with 1 ml of 3% trichloroacetic
acid and 1.5 ml of 1% thiobarbituric acid was added. The mixture
was then heated to 100‡C for 30 min and recooled on ice for 10
min before centrifugation in an Eppendorf centrifuge. Then superna-
tant was read at 530 nm. Results were expressed as WM TBARS/mg
of membrane proteins. B: The reaction mixture (25‡C) contained
mitochondria (0.25 mg protein/ml), 6 mM succinate, 1 WM CsA and
100 WM nitroblue tetrazolium in a ¢nal volume of 1 ml of incuba-
tion bu¡er described in Fig. 1. The reaction was started by adding
succinate and the rate of nitroblue tetrazolium reduction was mea-
sured at 600 nm. Anti A, antimycin A.
Table 1
CUR-induced oxidation of membrane protein thiols
Conditions thiol groups (%)
Control 100.0 þ 1.8
t-BH 1 mM 75.4 þ 7.3**
CUR 1 WM 94.6 þ 1.2*
CUR 2.5 WM 91.3 þ 1.5**
CUR 5 WM 88.4 þ 2.7**
CUR 10 WM 86.1 þ 5.9**
CUR 15 WM 84.1 þ 5.2**
CUR 20 WM 82.4 þ 3.4**
CUR 30 WM 83.2 þ 6.2**
Succinate 6 mM 99.3 þ 1.3
Succinate 6 mM+CUR 20 WM 87.6 þ 0.9**
Succinate 6 mM+CUR 20 WM+EGTA 100 WM 100.8 þ 2.1
Succinate 6 mM+CUR 20 WM+RR 1 WM 85.9 þ 3.3**
Control value, expressed as 100%, corresponds to 240 nmol of thiol
groups/mg proteins. Values represent the means þ S.D. of ¢ve ex-
periments in triplicate. *P6 0.05; **P6 0.01 compared to the con-
trol value.
RR, ruthenium red.
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zan, the inhibition of O32 formation by CUR is probably due
to a scavenger e¡ect of CUR towards O32 . In the same way,
CUR greatly diminished H2O2 formation, measured using the
method of Bagglioni et al. [32], the strongest e¡ect being ob-
served at 20 WM (data not shown). This property was con-
¢rmed in experiments on deenergized mitochondria where
mitochondrial swelling was induced by a high Ca2
concentration (100 WM) in the presence of tert-butylhydroper-
oxide (t-BH), a generator of alkoxyl or peroxyl radicals.
Under these particular conditions, pore opening was pre-
vented by CUR, with complete inhibition observed at 50
WM (Fig. 4B). This clearly demonstrates the duality of the
e¡ect of CUR which was able to induce or to prevent pore
opening depending on the experimental conditions.
Taken together these experiments con¢rm that CUR acts as
a radical scavenger of ROS and demonstrate that CUR-in-
duced PTP opening is not mediated by an overproduction of
these compounds. Therefore, we put the hypothesis of a pos-
sible thiol protein oxidation by CUR.
In initial experiments, we investigated the e¡ect of thiol
reagents on CUR-induced mitochondrial swelling. As dis-
cussed above, thiol oxidation or cross-linking increased PTP
opening probability, whereas thiol substitution or disul¢de
reduction prevented this e¡ect.
The thiol substitution compound N-ethylmaleimide (NEM)
completely prevented the CUR e¡ect, suggesting that a thiol
group is involved in swelling induction. However, in the same
experiment monobromobimane, which as NEM forms ad-
ducts with glutathione, was inactive. This seems to rule out
a possible role of glutathione in the mechanism of action of
CUR. This is strengthened by the fact that we were unable to
observe any interaction between CUR and glutathione, con-
¢rming the data of Oetari et al. [33]. In the same way, the
CUR e¡ect was insensitive to the reductant agent dithiothrei-
tol and to the polar monofunctional electrophilic SH reagent,
mersalyl (Fig. 4A).
Recently, Costantini et al. [34] made the assumption that
PTP opening might be modulated at two separate oxidation
sites in equilibrium with both the glutathione and the pyridine
nucleotide pools. Therefore, we tested whether the oxidation
of pyridine nucleotide was able to in£uence the CUR e¡ect.
The direct determination of pyridine nucleotide oxidation by
CUR by classical spectrophotometric and £uorimetric tech-
niques was impossible because both compounds absorb in
the same exact spectrum region. However, L-hydroxybutyrate,
which has been shown to reestablish pyridine nucleotide levels
and to inhibit the swelling induced by the pyridine nucleotide
oxidant acetoacetate [34], did not in£uence CUR-induced
swelling. In addition, omission of rotenone accelerated swell-
ing of energized mitochondria, indicating a protective e¡ect of
NADH. Thus, the oxidation of pyridine nucleotide did not
appear to be the cause of the CUR e¡ect. These data led to
the conclusion that oxidation of the glutathione and/or the
pyridine nucleotide pools is not a prerequisite to the modu-
lation of PTP opening by CUR. It may act on a site distinct
from those described by Costantini et al. [34]. This is in agree-
ment with data suggesting that di¡erent PTP inducers can
react with di¡erent protein thiol groups [35].
In a second series of experiments, deenergized mitochondria
were incubated in the presence of increasing concentrations of
CUR. Mitochondrial membrane proteins were extracted and
the content of the thiol group was determined using Ellman’s
reagent.
CUR induced a concentration-dependent decrease in free
thiol proteins, the maximal e¡ect being observed at 20 WM
and equivalent to that obtained with 1 mM of t-BH used as a
control (Table 1). Addition of succinate slightly impeded thiol
oxidation. This is probably due to the energization of the
transhydrogenase which reestablished NADPH to its normal
high levels and thus limited oxidation phenomenon [36]. Ca2
is necessary for the CUR e¡ects, since no oxidation could be
detected in the presence of EGTA. Interestingly, ruthenium
red was unable to prevent the CUR e¡ect. This indicates that
intramitochondrial Ca2 was not required to promote thiol
group oxidation whereas it was absolutely necessary to induce
mitochondrial swelling.
3.5. Mechanism by which curcumin induces PTP
CUR alters mitochondrial function and, more particularly,
induces opening of the PTP in liver mitochondria. This is a
paradoxical e¡ect for a drug which is a well-known antioxi-
dant described as a cytoprotective agent in di¡erent models
[37,38]. The present investigation con¢rms that CUR protects
mitochondria against the accumulation of ROS and the lipid
peroxidation of membranes and thus in our experimental con-
ditions PTP occurrence cannot be due to the production of
ROS which was suggested to induce apoptosis [15]. CUR does
not seem to involve an oxidation of either pyridine nucleotides
or of glutathione. This is in agreement with the data of Jaruga
et al. [39] demonstrating that CUR prevents glutathione loss
in dexamethasone-treated thymocytes. The mechanism of ac-
tion appears to involve a direct interaction with protein thiols
of the mitochondrial membrane which are supposed to con-
trol PTP opening [31]. The observation that the hydrophobic
reagent NEM prevented the CUR e¡ect whereas the more
hydrophilic reagents, monobromobimane and mersalyl, were
without e¡ect indicates that thiol groups must be embedded in
the membrane or localized in its hydrophobic environment.
These thiol groups probably belong to cysteine residues [31].
It should be noted that the hydrophobicity of the molecule
favors its insertion into biological membranes. The last ques-
tion is how CUR reacts with thiol groups. Flynn et al. [40]
have described the reaction of CUR with several nucleophilic
agents (N, S, O) giving birth to additive products. Such a
reaction could be considered with two juxtaposed thiols and
may represent a possible structure for the thiol^CUR inter-
action.
Ca2 is necessary to both CUR-induced oxidation and
swelling con¢rming its role in PTP induction. The observation
that ruthenium red inhibits mitochondrial swelling without
a¡ecting thiol oxidation indicates that intramitochondrial
Ca2 was not required to promote thiol groups but was ab-
solutely necessary to induce mitochondrial swelling. This can
be due to the binding of Ca2 to sites modulating PTP [25],
but also to mobilization of thiol groups by Ca2, thereby
stimulating their reactivity with a prooxidant [35].
In summary, CUR is able to oxidize mitochondrial mem-
brane thiol functions leading to PTP opening in the presence
of low Ca2 concentrations. The match between its protective
antioxidant e¡ect and its ability to induce PTP, a direct cause
of apoptosis, will probably drive the cell to choose between
life or death. We can speculate that the issue would depend on
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the nature of the cell and could explain the opposite e¡ect of
CUR observed with apoptosis [8^11]. This e¡ect may be one
of the steps of the mechanism by which CUR induces apo-
ptosis of tumor cells.
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